Enzim Devi Novonesis Faces Penalties for Competition Violations

Novonesis Group is facing a heavy penalty for abusing its dominant position in the industrial enzyme market, violating competition laws. The Competition Authority has determined that the company has engaged in exclusionary commercial practices against its competitors and has imposed an administrative fine of approximately 285 million TL on Novonesis.

Investigations revealed that Novonesis engaged in practices that undermine the genuine competitive environment in the market. The company continuously guaranteed its customers better prices than its competitors while also providing additional discounts on larger product purchases. However, this was not merely a financial incentive; it also had the objective of eroding the market share of competing firms.

In the statements of the Competition Authority, it is highlighted that Novonesis imposed the condition of not purchasing rival products through its practices. In this context, the company's commercial strategies aim to weaken the ability of other firms in the sector to exist in the market. Such practices, carried out in violation of the fundamental principles of competition law, threaten not only the profits of one company but also the overall dynamism of the sector.

While the industrial enzyme sector is rapidly growing worldwide, the preservation of its competitive structure is of great importance. The penalty imposed on Novonesis is an indication of how closely the effects of such actions and competition policies are monitored. Such sanctions will serve as a warning to other players in the sector, as a healthy competitive environment is a critical requirement for both consumer benefit and the sustainability of the market.